L04AB04 adalimumab
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 adalimumab
Medicines by ATC code L04AB04 adalimumab
- Hyrimoz Patient leaflet Summary of medicine characteristics
- Idacio Patient leaflet Summary of medicine characteristics
- Hukyndra Patient leaflet Summary of medicine characteristics
- Libmyris Patient leaflet Summary of medicine characteristics
- Hulio Patient leaflet Summary of medicine characteristics
- Amgevita Patient leaflet Summary of medicine characteristics
- Yuflyma Patient leaflet Summary of medicine characteristics
- Amsparity Patient leaflet Summary of medicine characteristics
- Hefiya Patient leaflet Summary of medicine characteristics
- Humira Patient leaflet Summary of medicine characteristics
- Imraldi Patient leaflet Summary of medicine characteristics
- Kromeya Patient leaflet Summary of medicine characteristics
- Cyltezo Patient leaflet Summary of medicine characteristics
- Solymbic Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: L04AB04 ADALIMUMAB
- French: L04AB04 adalimumab
- German: L04AB04 Adalimumab
- Spanish: L04AB04 ADALIMUMAB
- German: L04AB04 Adalimumab
- Italian: L04AB04 ADALIMUMAB
- Polish: L04AB04 ADALIMUMAB
- Turkish: L04AB04 adalimumab